C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2002
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002087587A2 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
11/07/2002	WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165251 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	US20020165240 Method of treating proliferative diseases using Eg5 inhibitors
11/07/2002	US20020165234 Selective B3 adrenergic agonists
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165094 Herbicidal synergistic composition, and method of controlling weeds
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2444500A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/06/2002	EP1254901A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002	EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	EP0879229B1 Arylpyrazole insecticides
11/06/2002	CN1378545A Substituted pyrroles as antiproliferative agents for treatment of cancer
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002	CN1093768C Diagnostic marker
11/06/2002	CN1093761C New pharmacological use of all-receptor antagonists
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476234 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
11/05/2002	US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085892A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	WO2002085866A1 Novel compounds
10/31/2002	WO2002085864A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085853A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085851A1 Pyrrole derivative
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085819A2 Production of tertiary amines by reductive amination
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161022 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/31/2002	US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002	US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002	US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002	US20020161004 Antiinflammation agents
10/31/2002	CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2444599A1 Melanocortin receptor ligands
10/31/2002	CA2444381A1 Novel compounds
10/31/2002	CA2444095A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/30/2002	EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002	EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002	EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002	EP0799221B1 Quinazolines as inhibitors of endothelin converting enzyme
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377343A Substituted aryl ketones
10/30/2002	CN1377268A Cell adhesion inhibitors
10/29/2002	US6472537 Polyamides for binding in the minor groove of double stranded DNA
10/29/2002	US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002	US6472529 Viricides
10/29/2002	US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists

1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 626